| Authors: |
Sahu M; Maitreyi Sahu (msahu1@bwh.harvard.edu), University of Washington, Seattle, Washington., Wagner TD; Tyler D. Wagner, National Pharmaceutical Council, Washington, D.C., DeJarnatt D; Drew DeJarnatt, Institute for Health Metrics and Evaluation, Seattle, Washington., Lescinsky H; Haley Lescinsky, Institute for Health Metrics and Evaluation., Beauchamp M; Meera Beauchamp, Institute for Health Metrics and Evaluation., Crosby SW; Sawyer W. Crosby, Institute for Health Metrics and Evaluation., Taylor K; Kayla Taylor, Institute for Health Metrics and Evaluation., Thomson A; Azalea Thomson, Institute for Health Metrics and Evaluation., Weil MS; Maxwell S. Weil, Institute for Health Metrics and Evaluation., Wittenauer R; Rachel Wittenauer, University of Washington., Dwyer-Lindgren L; Laura Dwyer-Lindgren, University of Washington., Haakenstad A; Annie Haakenstad, University of Washington., Qato DM; Dima Mazen Qato, University of Southern California, Los Angeles, California., Stergachis A; Andy Stergachis, University of Washington., Campbell JD; Jonathan D. Campbell, National Pharmaceutical Council., Dieleman JL; Joseph L. Dieleman, University of Washington. |
